Skip to main content

Table 1 Number of patients per cohort and time-point

From: Improved upper limb function in non-ambulant children with SMA type 2 and 3 during nusinersen treatment: a prospective 3-years SMArtCARE registry study

 

Baseline

m14

m26

m38

Younger sitters

107

87

74

52

Older sitters

73

69

55

40

Lost sitters

37

33

27

15

Lost walkers

39

36

32

22